EUVIMED · CrossrefZeitschrift
Cardiology Plus
ISSN 2470-7511 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Reconsider the future of interventional cardiology: restoration, reappraisal, and revolution
Cardiac rehabilitation and systolic blood pressure recovery after myocardial infarction
From risk factor modification to arterial-centered therapy: advancing a paradigm shift in atherosclerosis management
China’s fight against new-onset heart failure after acute myocardial infarction: a major stage victory
De novo heart failure in patients hospitalized with ST-segment elevation myocardial infarction in contemporary China
Clinical outcomes of transcatheter versus surgical aortic valve replacement in Lebanon: a retrospective analysis
Time to rename the “ischemia/reperfusion injury” model to “ischemia/delayed reperfusion injury” model?
Endocannabinoids and atherosclerosis: the future of therapeutic strategies—a review
Global status and trends in coronary chronic total occlusion over the period 2000–2023: a bibliometric analysis
Long-term clinical outcomes in elderly patients with chronic total occlusion and type 2 diabetes: the impact of coronary collateralization following successful recanalization
Injury mechanism of COVID-19–induced cardiac complications
Diabetes and associated cardiovascular complications: The role of microRNAs
Artificial intelligence in medical practice: current status and future perspectives
Low-dose aspirin for the prevention of atherothrombosis across the cardiovascular risk continuum
Calcific aortic valve stenosis and COVID-19: clinical management, valvular damage, and pathophysiological mechanisms
Aldehyde dehydrogenase 2-associated metabolic abnormalities and cardiovascular diseases: current status, underlying mechanisms, and clinical recommendations
Sacubitril-valsartan therapy in a patient with heart failure due to isolated left ventricular noncompaction: a case report and literature review
Serum N-terminal-pro-B-type natriuretic peptide is dependent on age and sex: a cross-sectional analysis in healthy adults from Northeast China
Managing residual inflammatory risk in atherosclerotic cardiovascular disease: another piece of the puzzle?
Duchenne muscular dystrophy and dilated cardiomyopathy with deletion of exon 45 and 49
Four aces of heart failure therapy: systematic review of established and emerging therapies for heart failure with reduced ejection fraction
Signaling pathways of inflammation in myocardial ischemia/reperfusion injury
Prognostic value of MELD-XI and MELD-Albumin scores in double valve replacement
Letter to the Editor: C-reactive protein and cardiovascular events in obstructive and nonobstructive coronary artery disease
ALDH2 mutation results in excessive basal nitric oxide production and a delayed response to nitroglycerin
Efficacy and safety of hybutimibe on primary hypercholesterolemia: a randomized, double-blinded, placebo and positive–controlled, parallel phase II study
Familial hypercholesterolemia in China requires greater efforts
Reply to Letter to the Editor: C-reactive protein and cardiovascular events in obstructive and nonobstructive coronary artery disease
Is Omega-3 Index necessary for fish oil supplements for CVD risk prevention?
Elevated plasma homocysteine level is associated with poor ST-segment resolution in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention at high altitude
EUVIMED